Introduction
The dominant hypothesis about the pathogenesis of Alzheimer's disease (AD) states that ␤-amyloid protein (A␤ 1-42 ) aggregates into toxic species able to disrupt synaptic function and eventually leading to neuronal loss (Walsh and Selkoe, 2007) . In Tg2576 mice expressing a human APP (amyloid precursor protein) variant linked to AD, a 56 kDa soluble A␤ assembly (A␤*56) disrupts memory (Lesné et al., 2006) . In the AD brain, both A␤ 1-42 monomers and dimers have been isolated (Klyubin et al., 2008; Shankar et al., 2008) , and dimers have been shown to impair synaptic plasticity in mouse hippocampal slices (Shankar et al., 2008) . Different from native A␤ 1-42 dimers and cell-secreted or synthetic oligomers, which are neurotoxic (Lambert et al., 1998; Walsh et al., 2002; Klyubin et al., 2008; Shankar et al., 2008) , A␤ 1-42 monomers are devoid of neurotoxicity in a number of different studies. We wondered whether A␤ 1-42 monomers could instead act to support neuronal survival. A␤ is found in the CSF of nondemented individuals (Shoji, 2002) , and has been implicated as a physiological regulator of synaptic activity (Kamenetz et al., 2003) . There is indirect evidence that A␤ 1-42 might be neuroprotective: (1) concentrations of A␤ in the cerebral interstitial fluid of patients with acute brain injury increase as their neurological status improves and fall as their neurological status declines (Brody et al., 2008) ; (2) addition of A␤ to cultured neurons enhances glucose uptake and metabolism via the induction of hypoxia-inducible factor-1␣ (Soucek et al., 2003) . We now provide a direct demonstration that A␤ 1-42 is neuroprotective, and that neuroprotection is a distinct feature of peptide monomers. In addition, we demonstrate that A␤ 1-42 monomers activate the phosphatidylinositol-3-kinase (PI-3-K) pathway, which is a major survival pathway in neurons (Franke et al., 1997) .
Materials and Methods
A␤ peptide preparation and analysis. A␤ 1-42 , A␤ 42-1 , and A␤ 1-40 were purchased from Bachem Distribution Services. A␤ 1-42 and A␤ 42-1 with the Arctic mutation E22G were obtained from Innovagen. A␤ peptides were dissolved in trifluoroacetic acid (TFA) at a concentration of 1 mg/ml and sonicated for 10 min. TFA was removed by gentle streaming of argon. Peptides were then dissolved in 1,1,1,3,3,3-hexa-fluoro-2-propanol (HFIP) and incubated at 37°C for 1 h. Following argon streaming, peptides were dissolved again in HFIP, lyophilized, and then resuspended in 5 mM anhydrous dimethyl sulfoxide (DMSO) before dilution to 100 M in ice-cold cell culture medium DMEM-F12. All peptide suspensions, with the exception of the Arctic peptides, were allowed to oligomerize overnight at 4°C, and different molecular weight-sized fractions were isolated by filtration through cutoff filters (50, 30, and 10 kDa). The Arctic peptides, which rapidly aggregate (Nilsberth et al., 2001) , were incubated for 15 min at room temperature before filtration. The peptide content of the recovered fractions was quantified by Bradford reagent. All samples were frozen briefly in liquid nitrogen and stored at Ϫ20°C until use.
Samples were examined by SDS-PAGE (12%) followed by Coomassie blue staining. For dot blot analysis, all different A␤ 1-42 samples (0.6 g of each) were spotted onto a nitrocellulose membrane. The membrane was first probed with anti-oligomer A11 antibody (Biosource, 1:1000), and then reprobed with the mouse anti A␤ 1-42 antibody (The Genetic Company, clone G2-13, 1:200) selective for C-terminal of A␤ . Horseradish peroxidaseconjugated secondary antibodies (Santa Cruz Biotechnology, 1:5000) were used, and signals were visualized using the enhancing chemiluminescence detection system (PerkinElmer LAS).
Atomic force microscopy (AFM) images were collected by using dynamic scanning force microscopy in air, using a Multimode/ Nanoscope IIIa (Digital Instruments) and etched-silicon probes (Nanosensors) with a pyramidal-shaped tip having a nominal curvature of 10 nm and a nominal internal angle of 35° (Pignataro et al., 2002) . Sampling of protein structures was randomly performed on at least three sample regions with area of ϳ2 m 2 . Each distribution histogram has been obtained by collecting from 500 to 1000 elements. Particles heights were measured by using the Nanoscope IIIA software, then gathered inside single datasets and statistically elaborated by Origin 8.
Culture preparation. Cultures of pure cortical neurons were obtained from rats at embryonic day 15 as described previously (Copani et al., 1999) . Cultures of mixed cortical cells, containing both neurons and glia, were obtained from rats at embryonic day 17 and grown onto poly-D-lysine coated 16 mm multiwell vessels (4 ϫ 10 5 cells/well) as described previously (Copani et al., 1991) . Mature cultures (14 -16 d in vitro) were used for the study.
Assessment of viability in pure neuronal culture. A␤ 1-42 peptides were applied to mature neuronal cultures between 8 and 12 d and maintained in the growing medium as long as necessary. For measurements of neuronal survival, assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction assay, A␤ 1-42 peptides were maintained up to 48 h. In the case of insulin deprivation, A␤ 1-42 monomers were added once and kept for 1 week.
Assessment of NMDA toxicity in culture. Both pure and mixed cortical cultures at maturation were exposed to 300 M NMDA for 10 min at room temperature in a HEPES-buffered salt solution. Neuronal toxicity was examined 24 h later by light microscopy and quantified after staining with trypan blue (0.4% for 5 min). Stained neurons were counted from threerandom fields/well. Lactate dehydrogenase release into the medium was also measured as described previously (Copani et al., 1991) . Peptide monomers were added in combination with NMDA. In some experiments, A␤ 1-42 monomers were added 24 h before the excitotoxic pulse or soon after the pulse and kept into the maintenance medium for 24 h. Where required, LY 294002 or UO126 (both at a concentration of 10 M) were applied 30 min before the NMDA pulse. AG1024 (100 nM) and picropodophyllin (500 nM) were applied 15 min before the excitotoxic pulse.
Western blot analysis. Western blot analysis was performed on total cell extracts (30 g/lane) from cultures of pure cortical neurons (Copani et Figure 1 . A␤ 1-42 monomers: separation, characterization, and lack of neurotoxicity in culture. A, B, AFM images of low-mass (Ͻ10 kDa, A) and high-mass (Ͼ50 kDa, B) A␤ 1-42 species isolated from a single suspension by cutoff filters. The respective frequencies of species in the two samples are shown on the right side. The monomer fraction consisted primarily of small globules 1.3 nm in height (mean Ϯ SD: 1.36 Ϯ 0.42, n ϭ 365). In contrast, the oligomer fraction consisted of larger globules 13 nm in height (mean Ϯ SD: 13.5 Ϯ 10.8, n ϭ 207). In B, the asterisk indicates structures derived from the aggregation of several oligomer species which were excluded from the statistics. C, Representative Western blot image of Bcl-2 bands in control cultures (C) and cultures treated with Ͻ10 kDa A␤ 1-42 for 6 h. ␤-Actin bands are shown for control of loading. Quantitation of Bcl-2/␤-actin ratioswasasfollows:control(C)ϭ0.7Ϯ0.1;Ͻ10kDaA␤ 1-42 ϭ1.2Ϯ0.03*(meansϮSEMofthreeindependentexperiments; *significantly different from control at p Ͻ 0.05 by Student's t test). Viability of pure cortical neurons, as measured by MTT assay, following 48 h treatment with different A␤ 1-42 fractions (all at 0.1 M) or different concentrations of Ͻ10 kDa A␤ , is shown in D and E, respectively. Values are means Ϯ SEM of eight determinations from two independent experiments. *p Ͻ 0.05 (one-way ANOVA ϩ Fisher's LSD) compared with control (CTRL).
al., 1999) treated with A␤ 1-42 monomers (0.1 M) for 10 min. Primary antibodies were as follows: rabbit anti-p(ser 9)-GSK-3␤, rabbit antip(ser 473)-AKT, rabbit anti-AKT, and rabbit anti-␤-catenin (all at 1:1000 dilution, Cell Signaling Technology). Other primary antibodies were as follows: rabbit anti-Bcl-2 (1:200 Santa Cruz Biotechnology), rabbit anti-p(tyr 1179)-IRS1 (1:500, Millipore), rabbit anti-p(ser 302)-IRS1 (1:1000, Cell Signaling Technology), rabbit anti-IRS1 (1:1000, Millipore), and mouse anti-␤-actin (1:500 Sigma-Aldrich). Specific hybridization signals were obtained by using horseradish peroxidase-conjugated secondary antibodies, followed by the enhancing chemiluminescence detection system (PerkinElmer LAS). Goat anti-rabbit antibodies labeled with IRDye 680 or IRDye 800 (1:10,000 dilution, LI-COR Biosciences) were used for IRS1 immunoblots, and hybridization signals were detected with the Odyssey Infrared Imaging System (LI-COR Biosciences). Western blot data were quantified by densitometric analysis of the hybridization signals in three different blots per experiment.
Liquid chromatography electrospray ionization mass spectrometry and matrix-assisted laser desorption ionization TOF/TOF analysis. Liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS) analysis was performed on culture-derived peptide solutions, i.e., 1 M A␤ 1-42 monomers in a HEPES-buffered salt solution, using a Thermo-Finnigan LCQ Deca XP instrument. The chromatographic analysis, coupled with ESI-MS detection, was performed on a Zorbax 300SB-C3 (2.1 ϫ 150 mm, 5 m particle size) column. For matrixassisted laser desorption ionization (MALDI) TOF/TOF analysis, the sample was separated with reverse-phase (RP) LC using a monolithic capillary column [200 m inner diameter ϫ 5 cm, made of PS-DVB (polystyrenedivinylbenzene polymer thermostatted at 60°C)] and spotted on the MALDI plate using an Ultimate HPLC system (LC Packing/ Dionex) coupled with a Probot Micro Fraction collector (LC Packing/ Dionex). The spotted samples were analyzed by a MALDI TOF/TOF tandem mass spectrometer (ABI 4800 Proteomics Analyzer, Applied Biosystems). Both MS and MS/MS data were acquired with a Nd:YAG laser, with a 200 Hz repetition rate.
Results
We obtained monomers and larger size oligomers (Ͼ50 kDa) from synthetic A␤ 1-42 by a modification of Lambert's protocol (Lambert et al., 1998) . At the AFM, the monomer fraction consisted of small globules of ϳ1.3 nm in height with little variation in size (Fig. 1A) . The various forms of A␤ aggregation were further characterized by SDS-PAGE and dot blot analysis with the A11 antibody, which detects oligomers but not monomers (supplemental Fig. 1 , available at www.jneurosci.org as supplemental material). As opposed to Ͼ50 kDa oligomers (0.1 M), monomers of A␤ 1-42 (0.1-1 M) were not toxic to pure cultures of rat cortical neurons (Fig. 1D, E) , but rather increased the expression of the antiapoptotic protein, Bcl-2 (Adams and Cory, 1998) (Fig.  1C) . We therefore tested the action of A␤ 1-42 monomers on different paradigms of neuronal death. We first assessed the effect of monomers on neurons that spontaneously degenerated when insulin was removed from the growing medium. Addition of A␤ 1-42 monomers (0.1 M) to the growing medium completely rescued neurons from death by trophic deprivation (Fig. 2 A) . We searched for an action of the A␤ 1-42 monomers on survival pathways that are stimulated by insulin, such as the extracellular regulated kinase (ERK1/2) pathway and the PI-3-K pathway (Avruch, 1998) . Interestingly, A␤ 1-42 monomers had no effect on ERK1/2 phosphorylation but activated the PI-3-K pathway, as shown by an enhanced phosphorylation of Akt (Fig. 2 B) . A␤ 1-42 monomers also enhanced Ser9 phosphorylation (inhibition) of the Akt substrate, glycogen-synthase kinase-3␤ (GSK-3␤) (Fig. 2 B) . Inhibition of GSK-3␤ promotes cell survival through a variety of mechanisms including a reduced degradation of ␤-catenin, which then translocates into the nucleus and activates the transcription of protective genes (Willert and Nusse, 1998) . As expected, intracellular levels of ␤-catenin showed a rapid and substantial increase in response to A␤ 1-42 monomers (Fig. 2 B) . The PI-3-K inhibitor, LY294002 (10 M) (Vlahos et al., 1994) , reduced the rescuing effect of A␤ 1-42 monomers on insulin-deprived neurons (Fig. 2 A) . We extended the study to a model of excitotoxic neuronal death, a process that contributes to the overall neurodegeneration in AD and other CNS disorders (Hynd et al., 2004) . We first challenged pure neuronal cultures with the excitotoxin, NMDA (300 M for 10 min), obtaining a small extent of neuronal death that was abrogated by coincubation with A␤ 1-42 monomers (supplemental Table 1 , available at www.jneurosci.org as supplemental material). We moved to mixed cultures of cortical cells (containing both neurons and astrocytes), which were more responsive to NMDA neurotoxicity. In these cultures, Ͼ50 kDa A␤ 1-42 oligomers were slightly Total AKT levels, ␤-actin bands, or total ERK levels are shown for control of loading. Quantitation of p(ser 473)-AKT/AKT ratios was as follows: control (C) ϭ 0.26 Ϯ 0.04; mA␤ 1-42 ϭ 0.65 Ϯ 0.1* (means Ϯ SEM of three independent experiments; *significantly different from control at p Ͻ 0.05 by Student's t test). Quantitation of p(ser 9)-GSK-3␤/GSK-3␤ ratios was as follows: control (C) ϭ 0.88 Ϯ 0.15; mA␤ 1-42 ϭ 1.44 Ϯ 0.08* (means Ϯ SEM of three independent experiments; *significantly different from control at p Ͻ 0.05 by Student's t test). Quantitation of ␤-catenin/ ␤-actin ratios was as follows: control (C) ϭ 0.47 Ϯ 0.05; mA␤ 1-42 ϭ 1.3 Ϯ 0.09* (means Ϯ SEM of three independent experiments; *significantly different from control at p Ͻ 0.05 by Student's t test). Quantitation of pERK 1/2/ERK 1/2 ratios was as follows: control (C) ϭ 0.6 Ϯ 0.08; mA␤ 1-42 ϭ 0.55 Ϯ 0.12 (means Ϯ SEM of three independent experiments).
toxic per se, and amplified NMDA toxicity at concentrations of 100 nM. A potentiation of NMDA toxicity was also observed at concentrations of oligomers (10 nM) that were per se devoid of toxicity (Fig. 3A) . In contrast, A␤ 1-42 monomers were neuroprotective in the 30 -100 nM concentration range (Fig. 3B) , and exhibited highly protective effects not only when combined with NMDA, but also when applied before or after the NMDA pulse (Fig. 3B) . The latter evidence excludes a direct interaction between A␤ 1-42 monomers and NMDA receptors. Monomers of A␤ 1-40 were also fully protective against NMDA toxicity, whereas monomers of the reverse peptide, A␤ 42-1 (supplemental Fig. 2 , available at www. jneurosci.org as supplemental material), protected to a lesser extent even at a concentration of 1 M (Fig. 3C) . We extended the study to monomers of A␤ (either 1-42 or 42-1), carrying the Arctic mutation (E22G) associated with familiar AD (Nilsberth et al., 2001 ) (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material). Interestingly, monomers of the two Arctic A␤ peptides lacked any neuroprotective activity (Fig. 3C ). Neuroprotection by A␤ 1-42 monomers against NMDA toxicity was again sensitive to the PI-3-K inhibitor, LY294002, but not to the ERK kinase inhibitor, UO126 (Favata et al., 1998) . Similarly, LY294002 reduced neuroprotection produced by monomeric A␤ 1-40 and A␤ 42-1 (Fig. 3D) . We also tested the activity of compound AG1024, which behaves as an inhibitor of all members of the insulin receptor superfamily, including the type-1 receptor for insulin-like growth factor-1 (IGF-1), and the activity of picropodophyllin (PPP), which is a selective inhibitor of the IGF-1 receptor ( Vasilcanu et al., 2004) . Both compounds mimicked the action of LY294002 in reducing neuroprotection by monomeric A␤ 1-42 and A␤ 42-1 (Fig. 3E) . AG1024 antagonized the phosphorylation of AKT and IRS1 (insulin receptor substrate 1) promoted by monomeric A␤ 1-42 , further indicating that the peptide effect involved the activation of IGF-1/insulin receptors (Fig. 3F ).
Discussion
Our data show that synthetic monomers of A␤ are able to support the survival of neurons developing under conditions of trophic deprivation, and also to protect mature neurons against excitotoxic death. The prosurvival effect of A␤ 1-42 monomers was mediated by the PI-3-K [mA␤(1-42) ]. Toxicity was induced by a 10 min pulse with 300 M NMDA and assessed by trypan blue staining (set to 100%) 24 h later. In the prepulse condition, A␤ 1-42 monomers were applied 24 h before the NMDA pulse and cultures were extensively washed before the experiment. In the postpulse condition, A␤ 1-42 monomers were applied soon after the excitotoxic pulse and kept for 24 h into the medium. Both in A and in B, values are means Ϯ SEM of 9 -18 determinations from three-six independent experiments. A, *Significantly different from the respective control (CTRL) at p Ͻ 0.05 (one-way ANOVA ϩ Fisher's LSD test). B, *Significantly different from NMDA at p Ͻ 0.001 (one-way ANOVA ϩ Fisher's LSD test). C, NMDA-induced toxicity in mixed cortical cultures is attenuated by the monomeric forms of A␤ 1-42 , A␤ 1-40 , and A␤ 42-1 , but not by A␤ pathway, which required the activation of IGF-1/insulin receptors. Accordingly, IRS1, which is a direct target of the IGF-1/ insulin receptor tyrosine kinase, was phosphorylated on tyr 1179 within 5 min of exposure to monomeric A␤. Monomeric A␤ also increased IRS1 phosphorylation on a serine residue (ser 302 in mice), which is required for an efficient insulin receptor signaling (Giraud et al., 2004) . It is possible that A␤ 1-42 monomers facilitate the activation of IGF-1/insulin receptors by locally produced IGF-1 or, alternatively, that A␤ monomers bind to IGF-1/insulin receptors, as already shown for A␤ oligomers (Xie et al., 2002; Townsend et al., 2007) .
A␤ monomers might oligomerize in the culture medium into peptide species that might contribute to neuroprotection. However, this is unexpected when the peptide is coapplied with NMDA during the brief excitotoxic pulse because of the slow kinetic of A␤ 1-42 self-association in vitro (Kusumoto et al., 1998) . LC-ESI mass spectrometry did not detect any A␤ 1-42 species (i.e., neither monomers nor oligomers) in the extracellular medium of cultures exposed to 1 M monomeric A␤ 1-42 for the time of the excitotoxic pulse. The more sensitive MALDI TOF mass spectrometry also failed to detect the peptide within the lower detection limit of 0.1 nM (data not shown). Monomeric A␤ has been shown to adsorb quickly and reversibly to lipid bilayers (Kremer and Murphy, 2003) , and, therefore, A␤ 1-42 monomers might have rapidly deposited on the plasma membranes in our cultures. Although we cannot exclude that membrane-bound A␤ 1-42 oligomers contribute to neuroprotection, this is unlikely because concentrations of oligomers as low as 10 nM did not attenuate but rather amplified excitotoxic death.
Our evidence that A␤ 1-42 monomers are neuroprotective is in line with the demonstration that inhibition of the A␤-synthesizing enzymes, ␤-or ␥-secretase, reduces neuronal viability (Plant et al., 2003) . It is tempting to speculate that aggregation of A␤ 1-42 , as occurs in the AD brain, might deplete A␤ 1-42 monomers, thus depriving neurons of a trophic support. The "loss-offunction" hypothesis of neuronal death must consider that monomers of A␤ 1-40 , which predominates over A␤ (Gregory and Halliday, 2005) , were also neuroprotective. The possibility that A␤ 1-40 monomers are also depleted in AD is suggested by the lower CSF levels of A␤ 1-40 in mild cognitive impairment patients with a more rapid cognitive decline (Hansson et al., 2007) . Data obtained with A␤ 42-1 and A␤ peptides carrying the Arctic mutation (either 1-42 or 42-1) provide some insights into the relationship between peptide structure and neuroprotection. AFM analysis showed that monomers of A␤ 1-42 and A␤ 42-1 have comparable dimensions, which is indicative of similar folding properties. This may explain the partial neuroprotective activity of A␤ 42-1 . In contrast, the substitution of a charged with a neutral amino acid (E22G) in the central portion of the Arctic peptides might have caused a substantial change in polypeptide conformational features [i.e., a more bent structure as suggested by AFM imaging (see supplemental Fig. 2 , available at www.jneurosci.org as supplemental material) (see also Rodziewicz-Motowidło et al., 2008) ] associated with a complete loss of neuroprotective activity. This, combined with the rapid aggregation kinetics of the Arctic peptide (Nilsberth et al., 2001; Rodziewicz-Motowidło et al., 2008) , might explain the aggressive and early-onset AD associated with this mutation.
Finally, the likeliness that A␤ 1-42 monomers subserve a prosurvival function in the brain implies that therapeutic strategies aimed at targeting A␤ should spare forms endowed with physiological functions.
